168 related articles for article (PubMed ID: 9572061)
1. Potential therapeutic value of drugs inhibiting semicarbazide-sensitive amine oxidase: vascular cytoprotection in diabetes mellitus.
Ekblom J
Pharmacol Res; 1998 Feb; 37(2):87-92. PubMed ID: 9572061
[TBL] [Abstract][Full Text] [Related]
2. Semicarbazide-sensitive amine oxidase: current status and perspectives.
Mátyus P; Dajka-Halász B; Földi A; Haider N; Barlocco D; Magyar K
Curr Med Chem; 2004 May; 11(10):1285-98. PubMed ID: 15134520
[TBL] [Abstract][Full Text] [Related]
3. Diabetes and semicarbazide-sensitive amine oxidase (SSAO) activity: a review.
Obata T
Life Sci; 2006 Jun; 79(5):417-22. PubMed ID: 16487546
[TBL] [Abstract][Full Text] [Related]
4. Involvement of SSAO-mediated deamination in adipose glucose transport and weight gain in obese diabetic KKAy mice.
Yu PH; Wang M; Fan H; Deng Y; Gubisne-Haberle D
Am J Physiol Endocrinol Metab; 2004 Apr; 286(4):E634-41. PubMed ID: 14656718
[TBL] [Abstract][Full Text] [Related]
5. Involvement of semicarbazide-sensitive amine oxidase-mediated deamination in atherogenesis in KKAy diabetic mice fed with high cholesterol diet.
Yu PH; Wang M; Deng YL; Fan H; Shira-Bock L
Diabetologia; 2002 Sep; 45(9):1255-62. PubMed ID: 12242458
[TBL] [Abstract][Full Text] [Related]
6. Selective inhibitors of membrane-bound semicarbazide-sensitive amine oxidase (SSAO) activity in mammalian tissues.
Kinemuchi H; Sugimoto H; Obata T; Satoh N; Ueda S
Neurotoxicology; 2004 Jan; 25(1-2):325-35. PubMed ID: 14697907
[TBL] [Abstract][Full Text] [Related]
7. The Impact of Semicarbazide Sensitive Amine Oxidase Activity on Rat Aortic Vascular Smooth Muscle Cells.
Manasieva V; Thakur S; Lione LA; Baydoun AR; Skamarauskas J
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902376
[TBL] [Abstract][Full Text] [Related]
8. Deamination of methylamine and angiopathy; toxicity of formaldehyde, oxidative stress and relevance to protein glycoxidation in diabetes.
Yu PH
J Neural Transm Suppl; 1998; 52():201-16. PubMed ID: 9564620
[TBL] [Abstract][Full Text] [Related]
9. Inhibitor sensitivity of human serum and vascular semicarbazide-sensitive amine oxidases.
Mészáros Z; Csányi A; Vallus G; Szombathy T; Karádi I; Magyar K
Neurobiology (Bp); 2000; 8(2):215-23. PubMed ID: 11061216
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous determination of formaldehyde and methylglyoxal in urine: involvement of semicarbazide-sensitive amine oxidase-mediated deamination in diabetic complications.
Deng Y; Yu PH
J Chromatogr Sci; 1999 Sep; 37(9):317-22. PubMed ID: 10497785
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the deamination of aminoacetone, an endogenous substrate for semicarbazide-sensitive amine oxidase.
Deng Y; Yu PH
Anal Biochem; 1999 May; 270(1):97-102. PubMed ID: 10328770
[TBL] [Abstract][Full Text] [Related]
12. Physiological and pathological implications of semicarbazide-sensitive amine oxidase.
Yu PH; Wright S; Fan EH; Lun ZR; Gubisne-Harberle D
Biochim Biophys Acta; 2003 Apr; 1647(1-2):193-9. PubMed ID: 12686132
[TBL] [Abstract][Full Text] [Related]
13. Aminoguanidine inhibits semicarbazide-sensitive amine oxidase activity: implications for advanced glycation and diabetic complications.
Yu PH; Zuo DM
Diabetologia; 1997 Nov; 40(11):1243-50. PubMed ID: 9389414
[TBL] [Abstract][Full Text] [Related]
14. Glucose handling in streptozotocin-induced diabetic rats is improved by tyramine but not by the amine oxidase inhibitor semicarbazide.
Visentin V; Bour S; Boucher J; Prévot D; Valet P; Ordener C; Parini A; Carpéné C
Eur J Pharmacol; 2005 Oct; 522(1-3):139-46. PubMed ID: 16202994
[TBL] [Abstract][Full Text] [Related]
15. 2-Bromoethylamine as a potent selective suicide inhibitor for semicarbazide-sensitive amine oxidase.
Yu PH; Davis BA; Deng Y
Biochem Pharmacol; 2001 Mar; 61(6):741-8. PubMed ID: 11266660
[TBL] [Abstract][Full Text] [Related]
16. Oxidative deamination of methylamine by semicarbazide-sensitive amine oxidase leads to cytotoxic damage in endothelial cells. Possible consequences for diabetes.
Yu PH; Zuo DM
Diabetes; 1993 Apr; 42(4):594-603. PubMed ID: 8454111
[TBL] [Abstract][Full Text] [Related]
17. Evidence for in vivo scavenging by aminoguanidine of formaldehyde produced via semicarbazide-sensitive amine oxidase-mediated deamination.
Kazachkov M; Chen K; Babiy S; Yu PH
J Pharmacol Exp Ther; 2007 Sep; 322(3):1201-7. PubMed ID: 17596537
[TBL] [Abstract][Full Text] [Related]
18. Production of a truncated soluble human semicarbazide-sensitive amine oxidase mediated by a GST-fusion protein secreted from HEK293 cells.
Ohman J; Jakobsson E; Källström U; Elmblad A; Ansari A; Kalderén C; Robertson E; Danielsson E; Gustavsson AL; Varadi A; Ekblom J; Holmgren E; Doverskog M; Abrahmsén L; Nilsson J
Protein Expr Purif; 2006 Apr; 46(2):321-31. PubMed ID: 16325418
[TBL] [Abstract][Full Text] [Related]
19. Developmental vasculotoxicity associated with inhibition of semicarbazide-sensitive amine oxidase.
Langford SD; Trent MB; Balakumaran A; Boor PJ
Toxicol Appl Pharmacol; 1999 Mar; 155(3):237-44. PubMed ID: 10079209
[TBL] [Abstract][Full Text] [Related]
20. [Determination of serum semicarbazide-sensitive amine oxidase activity in diabetic retinopathy in type-2 diabetes].
Dura E; Mészáros Z; Salacz G; Magyar K; Romics L; Karádi I
Orv Hetil; 2002 Nov; 143(47):2637-44. PubMed ID: 12532650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
